The dual role of p55 tumour necrosis factor-α receptor in Actinobacillus actinomycetemcomitans-induced experimental periodontitis: Host protection and tissue destruction

Clinical and Experimental Immunology

Volumn 147, Issue 1, 2007, Pages 128-138

  Garlet, G P ^a   Cardoso, C R B ^a   Campanelli, A P ^a   Ferreira, B R ^a   Avila Campos, M J ^a   Cunha, F Q ^a   Silva, J S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Actinobacillus actinomycetemcomitans; Chemokines; Inflammation; Periodontal diseases; TNF receptor p55; TNF

Indexed keywords

C REACTIVE PROTEIN; CHEMOKINE; CHEMOKINE CXCL3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR3; CXCL1 CHEMOKINE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE A; GELATINASE B; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERSTITIAL COLLAGENASE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MYELOPEROXIDASE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROTEIN P55; RANTES; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FLOW CYTOMETRY; HISTOLOGY; IMMUNE RESPONSE; IMMUNITY; INFLAMMATION; MALE; MOUSE; NONHUMAN; OSTEOLYSIS; PERIODONTITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ACTINOBACILLUS INFECTIONS; ALVEOLAR BONE LOSS; ANIMALS; ANTIBODIES, BACTERIAL; C-REACTIVE PROTEIN; CHEMOKINES, CC; CHEMOKINES, CXC; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-1BETA; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PERIODONTITIS; PERIODONTIUM; PEROXIDASE; RANK LIGAND; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RECEPTORS, INTERLEUKIN-8B; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR DECOY RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33845509723     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03260.x     Document Type: Article

References (45)

1. Baker PJ. The role of immune responses in bone loss during periodontal disease. Microbes Infect 2000; 2:1181-92.
2. Kinane DF, Lappin DF. Clinical, pathological and immunological aspects of periodontal disease. Acta Odontol Scand 2001; 59:154-60.
3. Graves DT, Cochran D. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 2003; 74:391-401.
4. Pfizenmaier K, Wajant H, Grell M. Tumor necrosis factors in 1996. Cytokine Growth Factor Rev 1996; 7:271-7.
5. Dinarello C. Proinflammatory cytokines. Chest 2000; 188:503-8.
6. Peschon JJ, Torrance DS, Stocking KL et al. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J Immunol 1998; 160:943-52.
7. Tervahartiala T, Koski H, Xu JW et al. Tumor necrosis factor-alpha and its receptors, p55 and p75, in gingiva of adult periodontitis. J Dent Res 2001; 80:1535-9.
8. Engebretson SP, Lamster IB, Herrera-Abreu M et al. The influence of interleukin gene polymorphism on expression of interleukin-1beta and tumor necrosis factor-alpha in periodontal tissue and gingival crevicular fluid. J Periodontol 1999; 70:567-73.
9. Assuma R, Oates T, Cochran D, Amar S, Graves DT. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol 1998; 160:403-9.
10. Oates TW, Graves DT, Cochran DL. Clinical, radiographic and biochemical assessment of IL-1/TNF-alpha antagonist inhibition of bone loss in experimental periodontitis. J Clin Periodontol 2002; 29:137-43.
11. Garlet GP, Avila-Campos MJ, Silva JS. Actinobacillus actinomycetencomitans-induced periodontal disease in mice: pattern of cytokines, chemokines, chemokine receptors expression and leukocyte migration. Microbes Infect 2005; 7:738-47.
12. Garlet GP, Cardoso CR, Silva TA et al. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. Oral Microbiol Immunol 2006; 2:12-20.
13. Souza MH, Lemos HP, Oliveira RB, Cunha FQ. Gastric damage and granulocyte infiltration induced by indomethacin in tumour necrosis factor receptor 1 (TNF-R1) or inducible nitric oxide synthase (iNOS) deficient mice. Gut 2004; 53:791-6.
14. Vilkuna-Rautiainen T, Pussinen PJ, Mattila K et al. Antigenically diverse reference strains and autologous strains of Actinobacillus actinomycetemcomitans are equally efficient antigens in enzyme-linked immunosorbent assay analysis. J Clin Microbiol 2002; 40:4640-5.
15. Abu-Amer Y, Ross FP, Edwards J, Teitelbaum SL. Lipopolysaccharide- stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. J Clin Invest 1997; 100:1557-65.
16. Gemmell E, Carter CL, Seymour GJ. Chemokines in human periodontal disease tissues. Clin Exp Immunol 2001; 125:134-41.
17. Liu RK, Cao CF, Meng HX, Gao Y. Polymorphonuclear neutrophils and their mediators in gingival tissues from generalized aggressive periodontitis. J Periodontol 2001; 72:1545-53.
18. Mizgerd JP, Spieker MR, Doerschuk CM. Early response cytokines and innate immunity. essential roles for TNF receptor 1 and type I IL-1 receptor during Escherichia coli pneumonia in mice. J Immunol 2001; 166:4042-8.
19. Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A. Characterization of cellular infiltrate, detection of chemokine receptor CCR5 and interleukin-8 and RANTES chemokines in adult periodontitis. J Periodont Res 2001; 36:194-203.
20. Garlet GP, Martins W Jr, Ferreira BR, Milanezi CM, Silva JS. Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. J Periodont Res 2003; 38:210-17.
21. Rot A, von Andrian UH. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 2004; 22:891-928.
22. Sedgwick JD, Riminton DS, Cyster JG, Korner H. Tumor necrosis factor: a master-regulator of leukocyte movement. Immunol Today 2000; 21:110-13.
23. Tessier PA, Naccache PH, Clark-Lewis I, Gladue RP, Neote KS, McColl SR. Chemokine networks in vivo: involvement of C-X-C and C-C chemokines in neutrophil extravasation in vivo in response to TNF-alpha. J Immunol 1997; 159:3595-602.
24. Vaday GG, Franitza S, Schor H et al. Combinatorial signals by inflammatory cytokines and chemokines mediate leukocyte interactions with extracellular matrix. J Leukoc Biol 2001; 69:885-92.
25. Wei S, Kitaura H, Zhou P, Ross FP, Teitelbaum SL. IL-1 mediates TNF-induced osteoclastogenesis. J Clin Invest 2005; 115:282-90.
26. Birkedal-Hansen H, Moore WG, Bodden MK et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993; 4:197-250.
27. Teitelbaum SL. Bone resorption by osteoclasts. Science 2000; 289:1504-8.
28. Pender SL, Fell JM, Chamow SM, Ashkenazi A, MacDonald TT. A p55 TNF receptor immunoadhesin prevents T cell-mediated intestinal injury by inhibiting matrix metalloproteinase production. J Immunol 1998; 160:4098-103.
29. Azuma Y, Kaji K, Katogi R, Takeshita S, Kudo A. Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J Biol Chem 2000; 275:4858-64.
30. Garlet GP, Martins W Jr, Fonseca BA, Ferreira BR, Silva JS. Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease. J Clin Periodontol 2004; 31:671-9.
31. Pfeffer K, Matsuyama T, Kundig TM et al. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 1993; 73:457-67.
32. Aliberti JC, Souto JT, Marino AP et al. Modulation of chemokine production and inflammatory responses in interferon-gamma- and tumor necrosis factor-R1-deficient mice during Trypanosoma cruzi infection. Am J Pathol 2001; 158:1433-40.
33. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340:448-54.
34. Leon LR, Kozak W, Peschon J, Kluger MJ. Exacerbated febrile responses to LPS, but not turpentine, in TNF double receptor-knockout mice. Am J Physiol 1997; 272:563-9.
35. Backes JM, Howard PA, Moriarty PM. Role of C-reactive protein in cardiovascular disease. Ann Pharmacother 2004; 38:110-8.
36. Offenbacher S, Beck JD. A perspective on the potential cardioprotective benefits of periodontal therapy. Am Heart J 2005; 149:950-4.
37. Chakravortty D, Hensel M. Inducible nitric oxide synthase and control of intracellular bacterial pathogens. Microbes Infect 2003; 5:621-7.
38. Carreras MC, Pargament GA, Catz SD, Poderoso JJ, Boveris A. Kinetics of nitric oxide and hydrogen peroxide production and formation of peroxynitrite during the respiratory burst of human neutrophils. FEBS Lett 1994; 341:65-8.
39. Shiloh MU, MacMicking JD, Nicholson S et al. Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity 1999; 10:29-38.
40. Spellberg B, Edwards JE Jr. Type 1/Type 2 immunity in infectious diseases. Clin Infect Dis 2001; 32:76-102.
41. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003; 3:133-46.
42. McArthur WP, Clark WB. Specific antibodies and their potential role in periodontal diseases. J Periodontol 1993; 64:807-18.
43. Schaible UE, Collins HL, Kaufmann SH. Confrontation between intracellular bacteria and the immune system. Adv Immunol 1999; 71:267-377.
44. Baker PJ, Howe L, Garneau J, Roopenian DC. T cell knockout mice have diminished alveolar bone loss after oral infection with Porphyromonas gingivalis. FEMS Immunol Med Microbiol 2002; 34:45-50.
45. Baker PJ, Roopenian DC. Genetic susceptibility to chronic periodontal disease. Microbes Infect 2002; 4:1157-67.